大洋集團(01991.HK)終止出售大洋(海南)健康產業發展100%股權
格隆匯 9 月 9日丨大洋集團(01991.HK)公告,於2020年9月9日,公司全資附屬公司大洋(海南)健康產業發展有限公司("賣方")與三亞德佑房地產投資服務有限公司("買方")訂立終止協議("終止協議"),以即時終止協議,據此,(i)任何訂約方均不得就協議相關事宜向對方提出申索。(ii)賣方須於2020年9月19日或前向買方退還金額為人民幣600萬元(免息)的第一期款項。
出售事項的完成須待若干先決條件獲達成後,方可作實,而出售事項應於協議生效日期起計90日內完成。
為籌備出售事項,公司已安排賣方將其於華融創投基金的100%權益轉讓予集團另一公司("集團內部重組")。於集團內部重組完成後,監於出售事項不會進行,目標公司、華融創投基金及大洋同創各自繼續為公司全資附屬公司。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.